Forschung + Publikationen

Wissenschaftliche
Schwerpunkte

Grundlagenforschung über die Pathogenese & Therapie des Typ-2-Diabetes, des Metabolischen Syndroms und der Adipositas
 Migration und Diabetes mellitus
 Anwendung von telemedizinischen Technologien in der Dialektologie
Klinische Forschung über die Behandlung von Adipositas, Diabetes und Lipidstoffwechselstörungen als Principal Investigator zahlreicher Studien und Klinischer Prüfungen in den Phasen 1, 2 und 3
Ernährungsmedizin
Originalarbeiten in zahlreichen Top-Journals, Übersichtsarbeiten, Buchbeiträge, zahlreiche Vorträge bei nationalen und internationalen Kongressen, Organisation von nationalen und internationalen Kongressen, Referent bei Fortbildungs-Veranstaltungen, Reviews in top Journalen (Diabetes, Diabetes Care, Diabetologia, European J. Clan. Investigation etc.)

Publikationen

Bücher:

  • Ludvik B (Ed): Risikofaktor Diabetes – Konzepte für ein Langzeitproblem. Uni-Med-Verlag Bremen, 1.Aufl. 2004 [ISBN: 3-89599-824-9]
  • Ludvik B, Toplak H: Medikamentöse Therapie der Adipositas. Springer Verlag Wien, 1.Aufl. 2006 [ISBN: 3-211-83815-5]
  • Mihaljevic K, Feffer S, Ludvik B: Essen mit Spass + Aktivsein mit Mass. So entkommen Sie dem Metabolischen Syndrom. Verlagshaus der Ärzte, 1.Aufl. 2006 [ISBN: 3-901488-75-8]
  • Pfeiffer A, Ludvik B, Kinzl J: Für immer dünn. Was Ärzte wirklich empfehlen. CD. Galila Hörbuchverlag. 1.Aufl. 2006 [ISBN: 3-902533-01-3]
  • Prager R, Abrahamian H, Kautzky-Willer A, Ludvik B, Schütz-Fuhrmann I, Weitgasser R: Diabetesmanagement mit Insulinanaloga. UNI-MED Verlag AG, 1. Auflage, 2008 [ISBN 978-3-89599-919-2]
  • Ludvik B, Fasching P, Lechleitner M, Prager R, Weitgasser R und Maierhofer W: Diabetes und seine Folgen verstehen – Gesundheitsratgeber. MedMedia Verlags- und Mediaservice GesmbH. 2. erweiterte Neuauflage 2011 [diabetes_guide_web.pdf 2,67 MB]

Buchbeiträge:

  • Weissel M, Punzengruber C, Hartter E, Burghuber OC, Ludvik B, Woloszczuk W: Effect of treatment with L-thyroxine on plansma ANP levels in athyreotic patients: indirect evidence for the necessity of adequate thyroid hormone levels to maintain normal ANP levels. In Advances in atrial peptide research. Vol 2 ed. Brenner BM, Saragh JH, Eds. 1988, p. 293-297
  • Graf H, Watzinger U, Ludvik B, Wagner A, Höcker B, Zweymuller KK: Eigenblutspende unter Erythropoietin – ein neues Konzept für elektive orthopädische Eingriffe. In 10 Jahre Zweymüller Hüftendoprothese. Zweymuller KK, Ed. 1990, p. 77-81
  • Kautzky-Willer A, Capek M, Pacini G, Ludvik B, Prager R: Insulin secretion, insulin sensitivity and hepatic insulin extraction in essential hypertension. In Current Topics in Diabetes Research. Karger Verlag, 1993, p. 250-253
  • Ludvik B: Adipositas – Diagnostik und Therapie. In Ernährungsmedizin. Widhalm K, Diallo-Ginstl E, Eds. ÖAK 2000, 334-346
  • Ludvik B: Konservative Therapie der morbiden Adipositas. In Morbide Adipositas – Klinik und Therapie. Hell E, Miller K, Eds. Ecomed 2000, 20-25
  • Ludvik B: Sekundäre Diabetesformen. In Diabetes in der Praxis. Waldhaeusl W, Gries FA, Scherbaum W, Eds. Springer Verlag Berlin 2004
  • Ludvik B: Diabetes mellitus: ein progerones Krankheitsbild. Therapie, Prävention und Einfluss von Lifestyle. In Angewandte Anti-Aging-Medizin. Gasser R (Hg). Verlagshaus der Ärzte 2004
  • Ludvik B, Bischof M, Kraupp M und Luger A: Diabetes mellitus und Lipidstoffwechsel. In Endokrinologie und Stoffwechsel – MCW Block 10. Facultas Verlags- und Buchhandels AG. 5. akt. Auflage 2011 [ISBN: 978-3-7089-0687-4]

Original- und Übersichts-Arbeiten:


  • Tobler, K., Freudenthaler, A., Baumgartner-Parzer, S.M., Wolzt, M., Ludvik, B., Nansalmaa, E., Nowotny, P.J., Seidinger, D., Steiner, S., Luger, A., Artwohl, M. Reduction of both number and proliferative activity of human endothelial progenitor cells in obesity. Int J Obes (Lond). 2010;34:687-700.
  • Schaller, G., Kretschmer, S., Gouya, G., Haider, D.G., Mittermayer, F., Riedl, M., Wagner, O., Pacini, G., Wolzt, M., Ludvik, B. Alcohol acutely increases vascular reactivity together with insulin sensitivity in
    type 2 diabetic men. Exp Clin Endocrinol Diabetes. 2010;118:57-60.
  • Maier, C., Riedl, M., Vila, G., Wolzt, M., Clodi, M., Ludvik, B., Luger, A. Differential regulation of plasma obestatin and ghrelin by meal intake and the cholinergic system in lean, but not obese individuals. J Clin Endocrinol Metab. 2010;95:E214-8.
  • Handisurya, A., Riedl, M., Vila, G., Maier, C., Clodi, M., Prikoszovich, T., Ludvik, B., Prager, G., Luger, A., Kautzky-Willer, A. Serum vaspin concentrations in relation to insulin sensitivity following RYGB-induced weight loss. Obes Surg. 2010;20:198-203.
  • Bohdjalian, A., Langer, F.B., Shakeri-Leidenmuhler, S., Gfrerer, L., Ludvik, B., Zacherl, J., Prager, G. Sleeve gastrectomy as sole and definitive bariatric procedure: 5-year results for weight loss and ghrelin. Obes Surg. 2010;20:535-40.
  • Vila, G., Riedl, M., Maier, C., Struck, J., Morgenthaler, N.G., Handisurya, A., Prager, G., Ludvik, B., Clodi, M., Luger, A. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery. Obesity (Silver Spring). 2009;17:1184-8.
  • Shakeri-Manesch, S., Zeyda, M., Huber, J., Ludvik, B., Prager, G., Stulnig, T.M. Diminished upregulation
    of visceral adipose heme oxygenase-1 correlates with waist-to-hip ratio and insulin resistance. Int J Obes (Lond). 2009;33:1257-64.
  • Schindler, K., Rieger, A., Tura, A., Gmeinhardt, B., Touzeau-Romer, V., Haider, D., Pacini, G., Ludvik, B.  The Effect of Rosiglitazone on Insulin Sensitivity, Beta Cell Function, Bone Mineral Density, and Body Composition in HIV-positive Patients on Highly-active Antiretroviral Therapy (HAART). Horm Metab Res. 2009;41:573-9.
  • Ludvik, B., Brath, H., Wascher, T., Toplak, H. [The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus]. Wien Klin Wochenschr. 2009;121:473-82.
  • Bohdjalian, A., Prager, G., Rosak, C., Weiner, R., Jung, R., Schramm, M., Aviv, R., Schindler, K., Haddad, W., Rosenthal, N., Ludvik, B. Improvement in glycemic control in morbidly obese type 2 diabetic subjects by gastric stimulation. Obes Surg. 2009;19:1221-7.
  • Bohdjalian, A., Ludvik, B., Guerci, B., Bresler, L., Renard, E., Nocca, D., Karnieli, E., Assalia, A., Prager, R., Prager, G. Improvement in glycemic control by gastric electrical stimulation (TANTALUS) in overweight subjects with type 2 diabetes. Surg Endosc. 2009;23:1955-60.
  • Riedl, M., Vila, G., Maier, C., Handisurya, A., Shakeri-Manesch, S., Prager, G., Wagner, O., Kautzky-Willer, A., Ludvik, B., Clodi, M., Luger, A. Plasma osteopontin increases after bariatric surgery and correlates
    with markers of bone turnover but not with insulin resistance. J Clin Endocrinol Metab. 2008;93:2307-12.
  • Morak, J., Schindler, K., Goerzer, E., Kastner, P., Toplak, H., Ludvik, B., Schreier, G. A pilot study of mobile phone-based therapy for obese patients. J Telemed Telecare. 2008;14:147-9.
  • Maier, C., Riedl, M., Vila, G., Nowotny, P., Wolzt, M., Clodi, M., Ludvik, B., Luger, A. Cholinergic regulation of ghrelin and peptide YY release may be impaired in obesity. Diabetes. 2008;57:2332-40.
  • Ludvik, B., Hanefeld, M., Pacini, G. Improved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects. Diabetes Obes Metab. 2008;10:586-92.
  • Langer, F.B., Bohdjalian, A., Shakeri-Manesch, S., Felberbauer, F.X., Ludvik, B., Zacherl, J., Prager, G. Inadequate weight loss vs secondary weight regain: laparoscopic conversion from gastric banding to Roux-en-Y gastric bypass. Obes Surg. 2008;18:1381-6.
  • Kiefer, F.W., Zeyda, M., Todoric, J., Huber, J., Geyeregger, R., Weichhart, T., Aszmann, O., Ludvik, B., Silberhumer, G.R., Prager, G., Stulnig, T.M. Osteopontin expression in human and murine obesity: extensive local up-regulation in adipose tissue but minimal systemic alterations. Endocrinology. 2008;149:1350-7.
  • Huber, J., Kiefer, F.W., Zeyda, M., Ludvik, B., Silberhumer, G.R., Prager, G., Zlabinger, G.J., Stulnig, T.M. CC chemokine and CC chemokine receptor profiles in visceral and subcutaneous adipose tissue are altered in human obesity. J Clin Endocrinol Metab. 2008;93:3215-21.
  • Brema, I., Hatunic, M., Finucane, F., Burns, N., Nolan, J.J., Haider, D., Wolzt, M., Ludvik, B. Plasma visfatin is reduced after aerobic exercise in early onset type 2 diabetes mellitus. Diabetes Obes Metab. 2008;10:600-2.
  • Vila, G., Maier, C., Riedl, M., Nowotny, P., Ludvik, B., Luger, A., Clodi, M. Bacterial endotoxin induces biphasic changes in plasma ghrelin in healthy humans. J Clin Endocrinol Metab. 2007;92:3930-4.
  • Tripp, B., Ludvik, B. [Antihypertensive and metabolic effects of telmisartan in patients with the metabolic syndrome in primary care–a field study]. Wien Med Wochenschr. 2007;157:223-7.
  • Kollmann, A., Riedl, M., Kastner, P., Schreier, G., Ludvik, B. Feasibility of a mobile phone-based data service for functional insulin treatment of type 1 diabetes mellitus patients. J Med Internet Res. 2007;9:e36.
  • Haider, D.G., Schindler, K., Prager, G., Bohdjalian, A., Luger, A., Wolzt, M., Ludvik, B. Serum retinol-binding protein 4 is reduced after weight loss in morbidly obese subjects. J Clin Endocrinol Metab. 2007;92:1168-71.
  • Haider, D.G., Schindler, K., Mittermayer, F., Muller, M., Nowotny, P., Rieger, A., Luger, A., Ludvik, B., Wolzt, M. Effect of rosiglitazone on visfatin and retinol-binding protein-4 plasma concentrations in HIV-positive patients. Clin Pharmacol Ther. 2007;81:580-5.
  • Haider, D.G., Schindler, K., Bohdjalian, A., Prager, G., Luger, A., Wolzt, M., Ludvik, B. Plasma adipocyte and epidermal fatty acid binding protein is reduced after weight loss in obesity. Diabetes Obes Metab. 2007;9:761-3.
  • Dorner, T., Fodor, J.G., Lawrence, K., Ludvik, B., Rieder, A. HDL-knowledge in the lay public: results of a representative population survey. Atherosclerosis. 2007;195:195-8.
  • Anderwald, C., Anderwald-Stadler, M., Promintzer, M., Prager, G., Mandl, M., Nowotny, P., Bischof, M.G., Wolzt, M., Ludvik, B., Kastenbauer, T., Pacini, G., Luger, A., Krebs, M. The Clamp-Like Index: a novel and highly sensitive insulin sensitivity index to calculate hyperinsulinemic clamp glucose infusion rates from oral glucose tolerance tests in nondiabetic subjects. Diabetes Care. 2007;30:2374-80.
  • Schindler, K., Haider, D., Wolzt, M., Rieger, A., Gmeinhart, B., Luger, A., Nowotny, P., Ludvik, B. Impact
    of antiretroviral therapy on visfatin and retinol-binding protein 4 in HIV-infected subjects. Eur J Clin Invest. 2006;36:640-6.
  • Riener, R., Schindler, K., Ludvik, B. Psychosocial variables, eating behavior, depression, and binge eating in morbidly obese subjects. Eat Behav. 2006;7:309-14.
  • Langer, F.B., Bohdjalian, A., Felberbauer, F.X., Fleischmann, E., Reza Hoda, M.A., Ludvik, B., Zacherl, J., Jakesz, R., Prager, G. Does gastric dilatation limit the success of sleeve gastrectomy as a sole operation for morbid obesity? Obes Surg. 2006;16:166-71.
  • Kautzky-Willer, A., Tura, A., Winzer, C., Wagner, O.F., Ludvik, B., Hanusch-Enserer, U., Prager, R., Pacini, G. Insulin sensitivity during oral glucose tolerance test and its relations to parameters of glucose metabolism and endothelial function in type 2 diabetic subjects under metformin and thiazolidinedione. Diabetes Obes Metab. 2006;8:561-7.
  • Haider, D.G., Schindler, K., Schaller, G., Prager, G., Wolzt, M., Ludvik, B. Increased plasma visfatin concentrations in morbidly obese subjects are reduced after gastric banding. J Clin Endocrinol Metab. 2006;91:1578-81.
  • Bohdjalian, A., Prager, G., Aviv, R., Policker, S., Schindler, K., Kretschmer, S., Riener, R., Zacherl, J., Ludvik, B. One-year experience with Tantalus: a new surgical approach to treat morbid obesity. Obes Surg. 2006;16:627-34.
  • Langer, F.B., Reza Hoda, M.A., Bohdjalian, A., Felberbauer, F.X., Zacherl, J., Wenzl, E., Schindler, K., Luger, A., Ludvik, B., Prager, G. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg. 2005;15:1024-9.
  • Cauza, E., Hanusch-Enserer, U., Strasser, B., Ludvik, B., Metz-Schimmerl, S., Pacini, G., Wagner, O., Georg, P., Prager, R., Kostner, K., Dunky, A., Haber, P. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. Arch Phys Med Rehabil. 2005;86:1527-33.
  • Cauza, E., Hanusch-Enserer, U., Strasser, B., Ludvik, B., Kostner, K., Dunky, A., Haber, P. Continuous glucose monitoring in diabetic long distance runners. Int J Sports Med. 2005;26:774-80.
  • Abrahamian, H., Ludvik, B., Schernthaner, G., Prager, R., Zellenka, U., Knudsen, L., Wascher, T. Improvement of glucose tolerance in type 2 diabetic patients: traditional vs. modern insulin regimens (results from the Austrian Biaspart Study). Horm Metab Res. 2005;37:684-9.
  • Tripp, B., Ludvik, B. [Pharmacotherapy of obesity]. Wien Med Wochenschr. 2004;154:320-8.
  • Tripp, B., Ludvik, B. [Novel anti-obesity drugs]. Acta Med Austriaca. 2004;31:133-8.
  • Schindler, K., Prager, G., Ballaban, T., Kretschmer, S., Riener, R., Buranyi, B., Maier, C., Luger, A., Ludvik, B. Impact of laparoscopic adjustable gastric banding on plasma ghrelin, eating behaviour and body weight. Eur J Clin Invest. 2004;34:549-54.
  • Schindler, K., Ludvik, B. [Assessment of body composition–methods and practical aspects]. Wien Med Wochenschr. 2004;154:305-12.
  • Ludvik, B., Neuffer, B., Pacini, G. Efficacy of Ipomoea batatas (Caiapo) on diabetes control in type 2 diabetic subjects treated with diet. Diabetes Care. 2004;27:436-40.
  • Ludvik, B. [Obesity]. Wien Med Wochenschr. 2004;154:295.
  • Bohdjalian, A., Langer, F., Reza Hoda, M.A., Felberbauer, F., Silberhumer, G., Zacherl, J., Schindler, K., Luger, A., Ludvik, B., Prager, G. [Surgical treatment of obesity]. Wien Med Wochenschr. 2004;154:329-33.
  • Tura, A., Pacini, G., Kautzky-Willer, A., Ludvik, B., Prager, R., Thomaseth, K. Basal and dynamic proinsulin-insulin relationship to assess beta-cell function during OGTT in metabolic disorders. Am J Physiol Endocrinol Metab. 2003;285:E155-62.
  • Ludvik, B., Waldhausl, W., Prager, R., Kautzky-Willer, A., Pacini, G. Mode of action of ipomoea batatas (Caiapo) in type 2 diabetic patients. Metabolism. 2003;52:875-80.
  • Ludvik, B., Thomaseth, K., Nolan, J.J., Clodi, M., Prager, R., Pacini, G. Inverse relation between amylin
    and glucagon secretion in healthy and diabetic human subjects. Eur J Clin Invest. 2003;33:316-22.
  • Ludvik, B.H., Mahdjoobian, K., Waldhaeusl, W., Hofer, A., Prager, R., Kautzky-Willer, A., Pacini, G. The effect of Ipomoea batatas (Caiapo) on glucose metabolism and serum cholesterol in patients with type 2 diabetes: a randomized study. Diabetes Care. 2002;25:239-40.
  • Georg, P., Kautzky-Willer, A., Mahdjoobian, K., Hofer, A., Prager, R., Pacini, G., Ludvik, B.H. Influence of metabolic control on splanchnic glucose uptake, insulin sensitivity, and the time required for glucose absorption in patients with type 1 diabetes. Diabetes Care. 2002;25:2042-7.
  • Tura, A., Ludvik, B., Nolan, J.J., Pacini, G., Thomaseth, K. Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT. Am J Physiol Endocrinol Metab. 2001;281:E966-74.
  • Mari, A., Pacini, G., Murphy, E., Ludvik, B., Nolan, J.J. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test. Diabetes Care. 2001;24:539-48.
  • Kautzky-Willer, A., Pacini, G., Tura, A., Bieglmayer, C., Schneider, B., Ludvik, B., Prager, R., Waldhausl, W. Increased plasma leptin in gestational diabetes. Diabetologia. 2001;44:164-72.
  • Georg, P., Ludvik, B. Metabolic changes in the ageing man. Wien Med Wochenschr. 2001;151:451-6.
  • Riedl, M., Ludvik, B., Pacini, G., Clodi, M., Kotzmann, H., Wagner, O., Kautzky-Willer, A., Prager, R., Luger, A. The increased insulin sensitivity in growth hormone-deficient adults is reduced by growth hormone replacement therapy. Eur J Clin Invest. 2000;30:771-8.
  • Ludvik, B. [Diabetes therapy related to etiology. Indications, uses and side effects of new insulin sensitizers]. MMW Fortschr Med. 2000;142:27-8.
  • Ludvik, B. [Weight loss by increasing energy consumption and thermogenesis]. Acta Med Austriaca. 1998;25:136-7.
  • Clodi, M., Thomaseth, K., Pacini, G., Hermann, K., Kautzky-Willer, A., Waldhusl, W., Prager, R., Ludvik, B.Distribution and kinetics of amylin in humans. Am J Physiol. 1998;274:E903-8.
  • Thomaseth, K., Pacini, G., Clodi, M., Kautzky-Willer, A., Nolan, J.J., Prager, R., Olefsky, J.M., Ludvik, B.Amylin release during oral glucose tolerance test. Diabet Med. 1997;14 Suppl 2:S29-34.
  • Nolan, J.J., Ludvik, B., Baloga, J., Reichart, D., Olefsky, J.M. Mechanisms of the kinetic defect in insulin action in obesity and NIDDM. Diabetes. 1997;46:994–1OOO.
  • Ludvik, B., Nolan, J.J., Roberts, A., Baloga, J., Joyce, M., Bell, J.M., Olefsky, J.M. Evidence for decreased splanchnic glucose uptake after oral glucose administration in non-insulin-dependent diabetes mellitus. J Clin Invest. 1997;100:2354-61.
  • Ludvik, B., Kautzky-Willer, A., Prager, R., Thomaseth, K., Pacini, G. Amylin: history and overview. Diabet Med. 1997;14 Suppl 2:S9-13.
  • Ludvik, B. [Amylin/IAPP (islet amyloid polypeptide)–physiology and clinical significance]. Wien Klin Wochenschr. 1997;109:379-83.
  • Kautzky-Willer, A., Thomaseth, K., Ludvik, B., Nowotny, P., Rabensteiner, D., Waldhausl, W., Pacini, G., Prager, R. Elevated islet amyloid pancreatic polypeptide and proinsulin in lean gestational diabetes. Diabetes. 1997;46:607-14.
  • Kautzky-Willer, A., Prager, R., Waldhausl, W., Pacini, G., Thomaseth, K., Wagner, O.F., Ulm, M., Streli, C., Ludvik, B. Pronounced insulin resistance and inadequate beta-cell secretion characterize lean gestational diabetes during and after pregnancy. Diabetes Care. 1997;20:1717-23.
  • Thomaseth, K., Kautzky-Willer, A., Ludvik, B., Prager, R., Pacini, G. Integrated mathematical model to assess beta-cell activity during the oral glucose test. Am J Physiol. 1996;270:E522-31.
  • Kautzky-Willer, A., Thomaseth, K., Clodi, M., Ludvik, B., Waldhausl, W., Prager, R., Pacini, G. Beta-cell activity and hepatic insulin extraction following dexamethasone administration in healthy subjects. Metabolism. 1996;45:486-91.
  • Ludvik, B., Nolan, J.J., Roberts, A., Baloga, J., Joyce, M., Bell, J.M., Olefsky, J.M. A noninvasive method
    to measure splanchnic glucose uptake after oral glucose administration. J Clin Invest. 1995;95:2232-8.
  • Ludvik, B., Nolan, J.J., Baloga, J., Sacks, D., Olefsky, J. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes. 1995;44:1121-5.
  • Kotzmann, H., Linkesch, M., Ludvik, B., Clodi, M., Luger, A., Schernthaner, G., Prager, R., Klauser, R. Effect of danazol-induced chronic hyperglucagonaemia on glucose tolerance and turnover. Eur J Clin Invest. 1995;25:942-7.
  • Kautzky-Willer, A., Pacini, G., Barnas, U., Ludvik, B., Streli, C., Graf, H., Prager, R. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int. 1995;47:200-6.
  • Nolan, J.J., Ludvik, B., Beerdsen, P., Joyce, M., Olefsky, J. Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone. N Engl J Med. 1994;331:1188-93.
  • Ludvik, B., Clodi, M., Kautzky-Willer, A., Schuller, M., Graf, H., Hartter, E., Pacini, G., Prager, R. Increased levels of circulating islet amyloid polypeptide in patients with chronic renal failure have no effect on insulin secretion. J Clin Invest. 1994;94:2045-50.
  • Kautzky-Willer, A., Thomaseth, K., Pacini, G., Clodi, M., Ludvik, B., Streli, C., Waldhausl, W., Prager, R. Role of islet amyloid polypeptide secretion in insulin-resistant humans. Diabetologia. 1994;37:188-94.
  • Capek, M., Schnack, C., Ludvik, B., Kautzky-Willer, A., Banyai, M., Prager, R. Effects of captopril treatment versus placebo on renal function in type 2 diabetic patients with microalbuminuria: a long-term study. Clin Investig. 1994;72:961-6.
  • Ludvik, B., Mayer, G., Stifter, S., Putz, D., Barnas, U., Graf, H. Effects of dichloroacetate on exercise performance in healthy volunteers. Pflugers Arch. 1993;423:251-4.
  • Ludvik, B., Clodi, M., Kautzky-Willer, A., Capek, M., Hartter, E., Pacini, G., Prager, R. Effect of dexamethasone on insulin sensitivity, islet amyloid polypeptide and insulin secretion in humans. Diabetologia. 1993;36:84-7.
  • Kautzky-Willer, A., Pacini, G., Weissel, M., Capek, M., Ludvik, B., Prager, R. Elevated hepatic insulin extraction in essential hypertension. Hypertension. 1993;21:646-53.
  • Kautzky-Willer, A., Pacini, G., Ludvik, B., Schernthaner, G., Prager, R. Beta-cell hypersecretion and not reduced hepatic insulin extraction is the main cause of hyperinsulinemia in obese nondiabetic subjects. Metabolism. 1992;41:1304-12.
  • Prager, R., Ludvik, B., Hartter, E. [Role of amylin in the pathogenesis of type II diabetes mellitus]. Acta Med Austriaca. 1991;18:61-2.
  • Ludvik, B., Peer, G., Berzlanovich, A., Stifter, S., Graf, H. Effects of dichloroacetate and bicarbonate on haemodynamic parameters in healthy volunteers. Clin Sci (Lond). 1991;80:47-51.
  • Ludvik, B., Lell, B., Hartter, E., Schnack, C., Prager, R. Decrease of stimulated amylin release precedes impairment of insulin secretion in type II diabetes. Diabetes. 1991;40:1615-9.
  • Ludvik, B., Kueenburg, E., Brunnbauer, M., Schernthaner, G., Prager, R. The effects of ramipril on glucose tolerance, insulin secretion, and insulin sensitivity in patients with hypertension. J Cardiovasc Pharmacol. 1991;18 Suppl 2:S157-9.
  • Hartter, E., Svoboda, T., Ludvik, B., Schuller, M., Lell, B., Kuenburg, E., Brunnbauer, M., Woloszczuk, W., Prager, R. Basal and stimulated plasma levels of pancreatic amylin indicate its co-secretion with insulin in humans. Diabetologia. 1991;34:52-4.
  • Hartter, E., Svoboda, T., Lell, B., Schuller, M., Ludvik, B., Woloszczuk, W., Prager, R. Reduced islet-amyloid polypeptide in insulin-dependent diabetes mellitus. Lancet. 1990;335:854.
  • Graf, H., Watzinger, U., Ludvik, B., Wagner, A., Hocker, P., Zweymuller, K.K. Recombinant human erythropoietin as adjuvant treatment for autologous blood donation. BMJ. 1990;300:1627-8.
  • Ludvik, B., Scheithauer, W., Wrba, F., Schratter, M., Schiessel, R., Schernthaner, G. [Gestagen receptor-positive, solid-cystic acinar-cell tumor of the pancreas]. Dtsch Med Wochenschr. 1989;114:903-6.
  • Wrba, F., Chott, A., Schratter, M., Ludvik, B., Krisch, K., Holzner, J.H. [Fine-needle puncture cytology of a solid cystic tumor of the pancreas]. Pathologe. 1988;9:340-4.
  • Wrba, F., Chott, A., Ludvik, B., Schratter, M., Spona, J., Reiner, A., Schernthaner, G., Krisch, K. Solid
    and cystic tumour of the pancreas; a hormonal-dependent neoplasm? Histopathology. 1988;12:338-40.
  • Ludvik, B., Niederle, B., Roka, R., Schernthaner, G., Neuhold, N. [Malignant aldosteronoma in the differential diagnosis of Conn syndrome]. Acta Med Austriaca. 1988;15:117-20.
  • Hay, U., Ludvik, B., Gisinger, C., Schernthaner, G. [Lack of effect of ACE inhibition on severe proteinuria
    in diabetic nephropathy–a 6-month-long study]. Schweiz Med Wochenschr. 1988;118:165-9.
  • Punzengruber, C., Hartter, E., Weissel, M., Burghuber, O.C., Ludvik, B., Woloszczuk, W. [Peripheral and right atrial plasma levels of atrial natriuretic peptide and their relation to mean atrial pressure]. Z Kardiol. 1987;76:72-5.
  • Weissel, M., Punzengruber, C., Hartter, E., Ludvik, B., Woloszczuk, W. Thyroid hormones and pericardial effusion may influence plasma levels of atrial natriuretic peptide (ANP) in humans. Klin Wochenschr. 1986;64 Suppl 6:93-6.
  • Hartter, E., Weissel, M., Stummvoll, H.K., Woloszczuk, W., Punzengruber, C., Ludvik, B. Atrial natriuretic peptide concentrations in blood from right atrium in patient with severe right heart failure. Lancet. 1985;2:93-4.